Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy: a Randomized Double-blind Trial (ERIKA Study)

NCT01629381 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.

NCT NCT01629381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01629381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy: a Randomized Double-blind Trial (ERIKA Study)
Lead sponsor
University of Padova
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
March 31, 2014
Enrollment
500 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

haemorrhage, venous thromboembolism